iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?The Motley Fool • 08/08/26
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?The Motley Fool • 08/03/26
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared DamageSeeking Alpha • 07/21/26
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?The Motley Fool • 07/09/26
This ETF Is Up Nearly 17% in a Month and Doesn't Own a Single Share of Nvidia24/7 Wall Street • 07/06/26
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.24/7 Wall Street • 06/20/26
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?The Motley Fool • 06/17/26
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBCCNBC • 06/16/26
The space race is coming for pharma: Why drug development is heading to lower Earth orbitCNBC • 06/09/26
‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-CovidCNBC • 06/04/26